When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
SPPI - Spectrum expands poziotinib clinical program
Spectrum Pharmaceuticals Inc.
Spectrum Pharmaceuticals (NASDAQ:SPPI) is further expanding its poziotinib clinical program by adding three new cohorts in ZENITH20 trial, evaluating the impact of poziotinib treatment on non-small cell lung cancer (NSCLC) patients.
More news on: Spectrum Pharmaceuticals, Inc., Healthcare stocks news,